Dialysis and Psoriasis
Authors: LARKIN M. WILSON
Journal: Annals of Internal Medicine (1978)

Letters and Corrections1 June 1978Dialysis and PsoriasisLARKIN M. WILSON, M.D.LARKIN M. WILSON, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-88-6-842 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: I read with interest the recent paper "Peritoneal Dialysis for Psoriasis (Ann Intern Med 88:349-351, 1978). The protocol description does not state whether heparin was used in the dialysis solution, which is customary. I think this may be important in regard to the improvement reported.In the early 1960s, we used intermittent heparin injections in certain patients with coronary heart disease. I recall two patients with severe psoriasis who had dramatic clearing of their lesions when this therapy was instituted.It might be interesting to use heparin alone in the reported patients should their lesions recur....References1. BUSELMEIERDAHLKJELLSTRANDGOLTZ TMCR: Dialysis therapy for psoriasis. JAMA, 1978, in press CrossrefGoogle Scholar2. BUSELMEIER T: Remission of psoriasis with dialysis treatment. Presented to the Society for Investigative Dermatology, University Hospital, Minneapolis, Minnesota, 10 February 1978 Google Scholar1. MCEVOYKELLY JA: Psoriatic clearance during hemodialysis. Ulster Med J 45:76-78, 1976 MedlineGoogle Scholar2. TWARDOWSKI Z: Abatement of psoriasis and repeated dialysis. Ann Intern Med 86:509-510, 1977 LinkGoogle Scholar3. MUSTONCONCEICAO HS: Remission of psoriasis during haemodialysis. Br Med J 1:480-481, 1978 CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: 714 West Faulkner; El Dorado, AR 71730 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByNonuremic Uses for DialysisPlasma exchange and leukapheresis in psoriasis ? no effect?Leukopheresis for treatment of psoriasis: Is therapeutical benefit related to reduced activities of neutral proteinases of polymorphonuclear leukocytes?Peritoneal Dialysis for Psoriasis: A Controlled StudyFREDERICK C. WHITTIER, M.D., DAN H. EVANS, M.D., PHILIP C. ANDERSON, M.D., KARL D. NOLPH, M.D.Dialysis and Haemofiltration for Non-Renal ConditionsPrinciples of Dialysis.Hemodialysis Therapy for PsoriasisDialysis for PsoriasisThe Activity of Polymorphonuclear Leukocyte Neutral Proteinases and Their Inhibitors in Patients with Psoriasis Treated with a Continuous Peritoneal DialysisHemodialysis in the Treatment of Psoriasis A Controlled TrialALLEN R. NISSENSON, M.D., MARVIN RAPAPORT, M.D., ARTHUR GORDON, M.D., ROBERT G. NARINS, M.D.Dialysis and PsoriasisHELMUT GRAF, M.D., AXEL WOLF, M.D., HANS KRISTER STUMMVOLL, M.D.Psoriasis During HemodialysisGUIDO O. PEREZ, M.D., JAMES R. OSTER, M.D., CARLOS A. VAAMONDE, M.D., KENNETH M. HALPRIN, M.D.Psoriasis Developing De Novo During HemodialysisELI A. FRIEDMAN, M.D., BARBARA G. DELANO, M.D.Neuere Entwicklungen in der DermatologieContinuous peritoneal dialysis for treatment of psoriasis 1 June 1978Volume 88, Issue 6Page: 842-843KeywordsCoronary heart diseaseHeparinLesionsMedical dialysisPeritoneal dialysisPsoriasis Issue Published: 1 June 1978 PDF DownloadLoading ...